-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Live Q&A

Program: Scientific Workshops @ ASH
Session: Engineered Immune Cells in the Management of Lymphoid Malignancies
Wednesday, December 2, 2020, 8:20 AM-9:55 AM

Katy Rezvani, MD, PhD

MD Anderson Cancer Center, Houston, TX

Disclosures: No relevant conflicts of interest to declare.

See more of: Engineered Immune Cells in the Management of Lymphoid Malignancies
See more of: Scientific Workshops @ ASH
<< Previous Presentation | Next Presentation